“The evidence does not support claims that the infections were caused by Olympus product designs or instructions for use,” a statement from the company said.
Olympus says its scopes are safe and effective when properly used, maintained and reprocessed according to their respective instructions for use.
“We regard the security and safety of patients and healthcare professionals as our top priority and will continue to develop safe and secure medical devices in cooperation with healthcare professionals,” the statement said.
The company is setting aside more than $85 million to cover losses expected to stem from a federal investigation into its scopes. It is also facing civil lawsuits in the U.S. related to the scopes.
More articles on clinical leadership and infection control:
Physicians find link between heroin use, spinal infections
74% of adults report barriers to traveling for specialty cancer care
Indiana VA hospital unveils building for sterilizing surgical tools, remodeled 4th floor
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
